S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
LON:ETX

e-therapeutics (ETX) Share Price, News & Analysis

GBX 15.90
-0.05 (-0.31%)
(As of 03:42 AM ET)
Today's Range
15.90
15.90
50-Day Range
8
18.13
52-Week Range
8
24
Volume
18,755 shs
Average Volume
382,000 shs
Market Capitalization
£92.91 million
P/E Ratio
N/A
Dividend Yield
3.35%
Price Target
N/A

ETX stock logo

About e-therapeutics Stock (LON:ETX)

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.

ETX Stock Price History

ETX Stock News Headlines

Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
The Next Nvidia?
Almost every investor has heard of Nvidia. The AI chipmaker became the 7th trillion-dollar company in history. Up 233% this year alone... 9,624% over the last decade. The exciting thing about investing in AI: Nvidia was just the beginning. Over the next few months, I expect a new wave of AI stocks to take the lead. Some could soar even higher than Nvidia.
e-therapeutics appoints new CFO
ETX.L - e-Therapeutics plc
Elicio Therapeutics Inc.
8-K: Seres Therapeutics, Inc.
e-Therapeutics plc (ETX.L)
e-therapeutics: Fundraise of £13.5 million
See More Headlines
Receive ETX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/17/2020
Today
2/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
34
Year Founded
N/A

Profitability

Net Income
£-10,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£295,000.00
Cash Flow
GBX 3.15 per share
Book Value
GBX 5 per share

Miscellaneous

Free Float
N/A
Market Cap
£93.20 million
Optionable
Not Optionable
Beta
0.48
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Ahmad Ali Mortazavi (Age 53)
    CEO & Director
    Comp: $270k
  • Mr. Timothy Bretherton
    CFO, Director of Finance & Operations and Company Secretary
  • Dr. Laura Roca-Alonso Ph.D.
    Chief Operating Officer
  • Mr. Alan Whitmore B.Sc.
    Ph.D., Chief Scientific Officer
  • Mr. Ankit Sharma
    Head of Software Engineering
  • Mr. Graham Craggs
    Head of Therapeutic Discovery














ETX Stock Analysis - Frequently Asked Questions

How have ETX shares performed in 2024?

e-therapeutics' stock was trading at GBX 8.24 at the beginning of 2024. Since then, ETX shares have increased by 93.0% and is now trading at GBX 15.90.
View the best growth stocks for 2024 here
.

How were e-therapeutics' earnings last quarter?

e-therapeutics plc (LON:ETX) released its quarterly earnings data on Tuesday, March, 17th. The company reported ($0.87) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.03.

What other stocks do shareholders of e-therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other e-therapeutics investors own include Radware (RDWR), Sound Energy (SOU), 4D pharma (DDDD), Chicken Soup for the Soul Entertainment (CSSE), Crescent Point Energy (CPG), Collagen Solutions plc (COS.L) (COS), BP (BP), Bushveld Minerals (BMN) and Alstom (ALSMY).

How do I buy shares of e-therapeutics?

Shares of ETX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ETX) was last updated on 2/23/2024 by MarketBeat.com Staff